Anatomage Releases The World’s First Complete Digitized Monkey
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Anatomage Inc., a pioneer in healthcare technology, announces the release of the world's...
News
ODAIA Named Only “Major Contender” and “Star Performer” in Everest Group’s PEAK Matrix® Assessment
Independent research firm honors ODAIA as a next-generation customer engagement platform for life sciences BOSTON, Nov. 18, 2024 /PRNewswire/ -- ODAIA today...
Guidehouse Adds Two Leaders to Growing Health Segment
Mark Korth and Angela Hunt, RN, join as partners to help healthcare organizations advance clinical and operational performance MCLEAN, Va.,...
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL,...
After 20 Years of Advocacy, First Exercise Prescription AI Software Set to Launch in December
VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ - Ginkgo Health Inc., a pioneering technology startup aiming to reduce the global healthcare...
Branch Selects Liberate’s Voice AI for FNOL and Digital Customer Experience
PALO ALTO, Calif., Nov. 18, 2024 /PRNewswire/ -- Branch, a full-stack insurance provider that uses data, technology and automation to make...
Sales Focus Inc. Founder & CEO Tony Horwath Featured on Better People Podcast
Better People Podcast featured Sales Focus Inc. Founder and CEO Tony Horwath on the Better People Podcast hosted by MidAtlantic...
Make-A-Wish joins forces with TikTok LIVE and Jason Derulo to host charitable live event
Proceeds from the fundraising event will help grant more life-changing wishes for children with critical illnesses PHOENIX, Nov. 18, 2024...
datma Joins GOAL Consortium as a Key Industry Supporter, Advancing Innovation in Academic Genomics and Precision Medicine
BEAVERTON, Ore., Nov. 18, 2024 /PRNewswire/ -- datma, a leading provider of federated Real-World Data platform and related analytical tools, today...
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
OPKO Healthcare's Veterinary Care Products to be Introduced at Asia's Largest Health and Nutrition Tradeshow Company Invited to Present at...
Semler Scientific® Announces BTC and ATM Activity Raised $21.5 million; Purchased Additional 215 BTC; Now Holds 1,273 BTC with BTC Yield of 37.3%
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology...
Bestqool Pro Advanced Series: Revolutionizing Red Light Therapy This Black Friday
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- With winter just around the corner, Bestqool is proud to offer a head start...
Webinar to Address Menopause in the Workplace
Program Will Focus on Supporting the Health and Careers of Women in Midlife WASHINGTON, DC / ACCESSWIRE / November 18,...
EW Healthcare Partners Announces Leadership Evolution
Dr. Petri Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding...
Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes
Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production UnitsLAS VEGAS, NV / ACCESSWIRE / November 18, 2024 /...
The Hash Corporation Announces Closing of Asset Sale, Name Change, and New Ticker Symbol “STRC.X”
Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Street Capital Inc. (CSE: REZN) (the "Company"), is pleased to announce that...
Mitochondrial Encephalopathy Caused by a New Biallelic Repeat Expansion
Scientists uncover a new biallelic GGGCC repeat expansion leading to NAXE-related mitochondrial encephalopathy in a three-year-old patient Short tandem DNA...
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a cash balance of...
Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 at The Liver Meeting® 2024
RTY-694 increased protein levels and function of ABCB4 and BSEP in primary hepatocytes, two transporters that play a key role in...
MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
Topline results expected in early January 2025CARMEL, Ind., Nov. 18, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a...